AVAH at a glance
Aveanna Healthcare Holdings, Inc. (AVAH, SEC CIK 1832332) filed its latest 10-K annual report on March 19, 2026, a 10-Q quarterly report on August 13, 2026, an 8-K current report on October 2, 2026 and Form 4 insider filings as recently as October 5, 2026. SignalX summarizes each filing with AI and tracks the company's insider trades and institutional holders.
- For the fiscal year ended January 3, 2026 (FY2025), Aveanna Healthcare Holdings, Inc. (AVAH) reported revenue of $2.4 billion (up 20.2% from FY2024) and net income of $225.0 million. Diluted EPS was $1.05.
- As of June 30, 2026, 30 institutional investment managers tracked by SignalX reported holding Aveanna Healthcare Holdings, Inc. (AVAH) shares worth $272.6 million in 13F-HR filings.
- The most recent insider open-market sale reported on Form 4 was by VIGANO PAUL R on August 21, 2026 of 2,250,000 shares at $11.50 per share.
- In the last 90 days, AVAH insiders reported 0 open-market purchases ($0) and 19 open-market sales ($558.5M) on Form 4, a net sale of $558.5M.
Source: SEC EDGAR (XBRL financial data, 13F-HR and Form 4 filings).
- Revenue · FY2025
- $2.4B
- +20.2% vs prior year
- Insiders · 90 days
- 0 buys · 19 sells
- Net −$558.5M
- 13F holders
- 30 funds
- $272.6M · −2 vs prior quarter
- Latest 8-K
- Aug 24, 2026
- Item 8.01
AI 10-Q Quarterly Report Analysis
Latest 10-Q, quarter ended Jul 4, 2026
Management Discussion & Analysis
- Revenue $670.5M, up 13.7% YoY from $589.6M
- Gross margin 32.6% vs 35.8%; operating margin 11.9% vs 13.6%
- PDS largest segment: revenue $553.9M, up 14.0%; margin 28.9% vs 32.5%
- Acquisition of Family First for $173.7M cash, funded with cash on hand
- Cost headwinds from higher caregiver labor costs and professional liability reserves
Risk Factors
- No risk-factors section provided; changes from the most recent 10-K cannot be assessed
- Rule 10b5-1 compliance risk: Chief Compliance Officer adopted sell-to-cover plan for up to 28,373 shares
- Financing risk: Thirteenth amendment to First Lien Credit Agreement dated May 26, 2026
- Liquidity risk: Eighth amendment to Receivables Financing Agreement dated June 25, 2026
AI summary of the AVAH 10-Q filed . Generated from the filing text; verify against the original.View on SEC EDGAR10-K vs 10-Q vs 8-K
AI 8-K Current Report Analysis
The most recent material events, by 8-K item
Item 8.01: Other Events
- Secondary offering sold 15,000,000 shares at $11.75 per share, representing substantial selling-stockholder liquidity
- Selling stockholders included J.H. Whitney affiliates and current and former directors and officers
Item 7.01: Regulation FD Disclosure
- Website designated as a distribution channel for material company information
- Investors directed to Aveanna’s “Investors” section for time-critical disclosures
Item EX-99.1: Item EX-99.1
- Q2 2026 revenue $670.5m, up 13.7%; Adjusted EBITDA $95.4m, up 8.0%
- Positive free cash flow $75.4m, improving $38.5m versus 2025; operating cash flow $85.3m
AI summaries of AVAH 8-K current reports filed with the SEC. What 8-K item codes mean
SignalX for AVAH
Don't miss the next AVAH filing
- Alerts as it files. A push when AVAH files an 8-K or an insider trades.
- Fund moves. Which tracked funds opened, added or cut AVAH, by share count.
- Ask anything. An AI agent that reads every AVAH filing and answers with sources.
AVAH alerts on your phone. Follow it in the SignalX Android app.
Recent Insider Transactions (Form 4)
Latest reported trades by officers, directors and 10% owners
| Insider | Type | Date | Shares | Price |
|---|---|---|---|---|
| Stewart Deborah | A | Oct 1, 2026 | 75,000 | - |
| VIGANO PAUL R | Sell | Aug 21, 2026 | 2,250,000 | $11.50 |
| WILLIAMS ROBERT M JR | Sell | Aug 21, 2026 | 2,250,000 | $11.50 |
| J.H. Whitney Equity Partners VII, LLC | Sell | Aug 21, 2026 | 2,250,000 | $11.50 |
| Windley Rodney D | Sell | Aug 20, 2026 | 180,000 | $11.50 |
| WILLIAMS ROBERT M JR | Sell | Aug 20, 2026 | 957,918 | $11.50 |
| Shaner Jeff | Sell | Aug 20, 2026 | 90,000 | $11.50 |
| VIGANO PAUL R | Sell | Aug 20, 2026 | 957,918 | $11.50 |
Financial SummaryXBRL
| Metric | FY2023 | FY2024 | FY2025 |
|---|---|---|---|
| Profitability | |||
| Revenue | - | $2.0B | $2.4B |
| Gross Profit | $595.4M | $635.5M | $810.5M |
| Operating Income | $8.1M | $139.8M | $256.5M |
| Net Income | - | -$10.9M | $225.0M |
| Gross Margin | - | 31.4% | 33.3% |
| Op. Margin | - | 6.9% | 10.5% |
| Net Margin | - | -0.5% | 9.2% |
| Balance Sheet | |||
| Total Assets | $1.6B | $1.7B | $2.0B |
| Equity | - | -$123.6M | $194.5M |
| ROE | - | 8.8% | 115.7% |
| Per Share | |||
| EPS | $-0.71 | $-0.06 | $1.05 |
| Cash Flow | |||
| Operating CF | - | $32.6M | $125.9M |
Source: XBRL data in Aveanna Healthcare Holdings, Inc. (AVAH)'s 10-K filings on SEC EDGAR, in USD. Compare across companies →
13F Fund Holdings: Quarterly Trend
Latest: Q2 2026Aggregate AVAH share value held by 13F filers tracked by SignalX, by quarter.
Quarterly totals table
| Quarter | Funds | Total value |
|---|---|---|
| Q2 2026 | 30 | $272.6M |
| Q1 2026 | 32 | $147.7M |
| Q4 2025 | 26 | $188.6M |
| Q3 2025 | 25 | $142.5M |
| Q2 2025 | 25 | $64.3M |
| Q1 2025 | 19 | $33.0M |
| Q4 2024 | 15 | $24.9M |
| Q3 2024 | 11 | $16.0M |
- Citadel Advisors LLC+2.01M (+725%)
- BlackRock+1.91M (+35%)
- FMR LLC (Fidelity)+1.17M (+320%)
- JPMorgan Chase & Co+1.05M (+232%)
- Dimensional Fund Advisors+923.3K (+69%)
- Vanguard Capital Management LLC−301.6K (-8%)
- Morgan Stanley−269.0K (-17%)
- Two Sigma Investments−175.3K (-13%)
- Renaissance Technologies LLC−89.8K (-10%)
- Mangrove Partners−61.8K (-57%)
- Millennium Management−750.6K
- Marex Group plc−50.0K
- U.S. Bancorp−28
Source: 13F-HR filings on SEC EDGAR (aggregated from 183 fund-quarter rows). Reflects only 13F filers tracked by SignalX, not the full institutional ownership universe. How 13F filings work
AVAH filing archive
AI analysis pages for each 10-K, 10-Q and 8-K
Latest 2026 SEC Filings: 10-K, 10-Q, 8-K & Form 4
| Form | Filing date | Period | Analysis | SEC |
|---|---|---|---|---|
| 4 | Oct 5, 2026 | - | - | - |
| 8-K | Oct 2, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 8-K | Aug 24, 2026 | - | Analysis | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 4 | Aug 24, 2026 | - | - | - |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 10-Q | Aug 13, 2026 | Jul 4, 2026 | Analysis | |
| 8-K | Aug 13, 2026 | - | Analysis | - |
| 8-K | Aug 7, 2026 | - | Analysis | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jul 2, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 26, 2026 | - | - | - |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 4 | Jun 5, 2026 | - | - | |
| 8-K | Jun 2, 2026 | - | Analysis | |
| 8-K | May 29, 2026 | - | Analysis | |
| 8-K | May 28, 2026 | - | Analysis |
Related Health Care companies
- AHCO · AdaptHealth Corp.Services-Home Health Care Services
- ADUS · Addus HomeCare CorpServices-Home Health Care Services
- BTSG · BrightSpring Health Services, Inc.Services-Home Health Care Services
- CHE · Chemed CorpServices-Home Health Care Services
- EHAB · Enhabit, Inc.Services-Home Health Care Services
- OPCH · Option Care Health, Inc.Services-Home Health Care Services
- TXG · 10x Genomics, Inc.Laboratory Analytical Instruments
- FDMT · 4D Molecular Therapeutics, Inc.Biological Products, (No Diagnostic Substances)
AVAH SEC filings: frequently asked questions
Are AVAH insiders buying or selling?
In the last 90 days, Aveanna Healthcare Holdings, Inc. (AVAH) officers, directors and 10% owners reported no open-market purchases and 19 open-market sales worth $558.5 million by 6 insiders on Form 4. Many insider sales are pre-planned or for taxes, so purchases usually carry more information.
Which institutions hold AVAH stock?
As of June 30, 2026, the largest Aveanna Healthcare Holdings, Inc. (AVAH) holders among the 13F filers tracked by SignalX were BlackRock ($63.5 million), Vanguard Capital Management LLC ($31.5 million), Citadel Advisors LLC ($19.6 million), Dimensional Fund Advisors ($19.3 million), State Street Corp ($16.7 million). 13F-HR reports are filed up to 45 days after each quarter ends.
What was AVAH's revenue in fiscal year 2025?
For the fiscal year ended January 3, 2026 (FY2025), Aveanna Healthcare Holdings, Inc. (AVAH) reported revenue of $2.4 billion (up 20.2% from FY2024) and net income of $225.0 million. Diluted EPS was $1.05. The figures come from the XBRL data in the 10-K.
What did AVAH report in its latest 8-K?
Aveanna Healthcare Holdings, Inc. (AVAH) filed an 8-K on August 24, 2026 reporting Item 8.01 (Other Events). Secondary offering sold 15,000,000 shares at $11.75 per share, representing substantial selling-stockholder liquidity.
What are the latest AVAH SEC filings?
Aveanna Healthcare Holdings, Inc. (AVAH) filed its latest 10-K annual report on March 19, 2026, a 10-Q quarterly report on August 13, 2026, an 8-K current report on October 2, 2026 and a Form 4 insider filing on October 5, 2026.
What is AVAH's SEC CIK number?
Aveanna Healthcare Holdings, Inc. (AVAH)'s SEC Central Index Key (CIK) is 1832332. EDGAR lists every AVAH filing under that number.
Ask anything about AVAH
The research agent reads AVAH's filings, financials, insider trades and 13F holders, then answers with sources.